# Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects

> **NCT04587713** · PHASE1 · COMPLETED · sponsor: **Theravance Biopharma** · enrollment: 58 (actual)

## Conditions studied

- Intestinal Disorder
- Bowel Diseases, Inflammatory

## Interventions

- **DRUG:** TD-1473 [Tablet A]
- **DRUG:** TD-1473 [Tablet B]

## Key facts

- **NCT ID:** NCT04587713
- **Lead sponsor:** Theravance Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-16
- **Primary completion:** 2020-12-24
- **Final completion:** 2020-12-27
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2021-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04587713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04587713, "Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04587713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*